|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
3/2021
vol. 123 abstract:
Review paper
Phytocannabinoids and the eye – a systematic review
Anna Wolnik
1
,
Małgorzata Woś
1
,
Jerzy Mackiewicz
2
KLINIKA OCZNA 2021, 123, 3: 114–121
Online publish date: 2021/10/13
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Recently, the use of marihuana for medical purposes has become more common. It can lead to many desired effects within the eye, as well as several adverse ones (i.a.: decrease in intraocular pressure, reduction of corneal pain and suppression of inflammation after chemical injury of cornea, treatment of blepharospasm, reduction of nystagmus, decrease in corneal endothelial cell density, eye irritation). There have not been enough studies with human subjects done on the safety and effectiveness of cannabis use in ophthalmology. Although synthetic cannabinoids combined with modulation of the endocannabinoid system might become the future of ophthalmology, more studies on this topic should be conducted.
keywords:
marijuana (marihuana), medical marijuana (marihuana), phytocannabinoids, Δ-9-tetrahydrocannabinol |
|
POLSKI
